The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...